TARS Competitors & Alternatives
Compare Tarsus Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
TARS
Main Stock$72.33
Tradestie Score
33
Market Cap
$2.42B
Revenue Growth
0.7%
Analyst Upside
+31.2%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$26.89
|
$3.31B | - | 60 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 48 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$25.71
|
$3.09B | - | 42 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$32.99
|
$3.08B | - | 54 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$40.50
|
$3.03B | - | 48 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$60.57
|
$3.02B | - | 58 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$79.22
|
$3.01B | - | 39 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 50 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$25.67
|
$2.89B | - | 57 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$43.62
|
$2.85B | - | 36 | Compare |
More TARS Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2836)
236 stocks in this industry